NCT04119817View on ClinicalTrials.gov

Effects of Mucosave® on Gastrointestinal Discomfort

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 9, 2019

Primary Completion Date

May 22, 2019

Study Completion Date

July 22, 2019

Conditions
Gastrointestinal Discomfort
Interventions
DIETARY_SUPPLEMENT

Mucosave® capsules

400 mg/day of Mucosave® capsules for a period of 8 weeks, once a day.

DIETARY_SUPPLEMENT

Placebo

400 mg/day of placebo capsules for a period of 8 weeks, once a day.

Trial Locations (1)

98125

Gioacchino Calapai, Messina

All Listed Sponsors
lead

"Azienda Ospedaliera Universitaria Policlinico G. Martino"

OTHER

NCT04119817 - Effects of Mucosave® on Gastrointestinal Discomfort | Biotech Hunter | Biotech Hunter